HP has appointed former GlaxoSmithKline chief and Microsoft board member Emma Walmsley as its next chief executive officer. The leadership change directly targets a tightening global memory chip supply caused by heavy investments in AI data centers. Walmsley will take over from interim executive Bruce Broussard early next year.
Walmsley led pharmaceutical giant GlaxoSmithKline from 2017 until late 2025 and currently serves on the board at Microsoft. She brings no direct tech hardware manufacturing experience to the role. HP expects her corporate governance experience to stabilize business lines as the company tries to capture corporate demand for personal computers built for AI workloads.
HP faces the same silicon supply constraints as competitors Dell, Apple, and Lenovo. Massive enterprise data center construction projects are consuming available memory manufacturing capacity worldwide. This supply shift leaves PC makers competing for constrained DRAM allocations, which pushes component costs higher across the consumer and enterprise markets.
Third quarter financial disclosures show the immediate impact of these market pressures. HP grew revenue in its PC division by 18%, yet unit shipments dropped 16%. The divergence stems from an intentional production pivot toward higher margin hardware, including specialized computers equipped for local artificial intelligence processing.
